Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection.
Ascione A, De Luca M, Tartaglione MT, Lampasi F, Di Costanzo GG, Lanza AG, Picciotto FP, Marino-Marsilia G, Fontanella L, Leandro G. Ascione A, et al. Among authors: de luca m. Gastroenterology. 2010 Jan;138(1):116-22. doi: 10.1053/j.gastro.2009.10.005. Epub 2009 Oct 20. Gastroenterology. 2010. PMID: 19852964 Clinical Trial.
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
Ascione A, De Luca M, Canestrini C, Di Costanzo GG, Raimondo G, Longo G, Manns MP, Tillmann HL, Forte GB, Rocco P, Biceglia O, Faleo D, Vinelli F, Cela EM, Amitrano L, Addario L, Gigliotti T. Ascione A, et al. Among authors: de luca m. Ital J Gastroenterol Hepatol. 1998 Oct;30(5):517-23. Ital J Gastroenterol Hepatol. 1998. PMID: 9836109 Clinical Trial.
Incidence of side effects during therapy with different types of alpha interferon: a randomised controlled trial comparing recombinant alpha 2b versus leukocyte interferon in the therapy of naive patients with chronic hepatitis C.
Ascione A, De Luca M, Di Costanzo GG, Picciotto FP, Lanza AG, Canestrini C, Morisco F, Tuccillo C, Caporaso N. Ascione A, et al. Among authors: de luca m. Curr Pharm Des. 2002;8(11):977-80. doi: 10.2174/1381612024607018. Curr Pharm Des. 2002. PMID: 11945144 Clinical Trial.
Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
Addario L, Scaglione G, Tritto G, Di Costanzo GG, De Luca M, Lampasi F, Galeota Lanza A, Picciotto FP, Tartaglione MT, Utech W, Macr M, Giannelli E, Ascione A. Addario L, et al. Among authors: de luca m. Eur J Gastroenterol Hepatol. 2006 Jul;18(7):713-20. doi: 10.1097/01.meg.0000219104.40435.43. Eur J Gastroenterol Hepatol. 2006. PMID: 16772827
Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG, Tartaglione MT, Picciotto FP, Ascione A. Di Costanzo GG, et al. Among authors: de luca m. Eur J Gastroenterol Hepatol. 2008 Jul;20(7):674-9. doi: 10.1097/MEG.0b013e3282f762e1. Eur J Gastroenterol Hepatol. 2008. PMID: 18679071
[Prevalence of antibody to hepatitis C virus in hospital personnel].
De Luca M, Ascione A, Canestrini C, Di Costanzo GG, Galeota Lanza A, Guardascione MA, Gallo ML, Parisio Perrotti G, Samaritani CM, Utech W, et al. De Luca M, et al. Minerva Gastroenterol Dietol. 1991 Jul-Sep;37(3):141-9. Minerva Gastroenterol Dietol. 1991. PMID: 1724181 Italian.
1,282 results